Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb(th-3) Mouse Model

समान संसाधन

• Hematopoietic Stem Cell Mobilization for Gene Therapy: Superior Mobilization by the Combination of Granulocyte–Colony Stimulating Factor Plus Plerixafor in Patients with β-Thalassemia Major
  द्वारा: Yannaki, Evangelia, और अन्य
  प्रकाशित: (2013)
• Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects
  द्वारा: Yannaki, Evangelia, और अन्य
  प्रकाशित: (2012)
• Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in beta-thalassemia major patients
  द्वारा: Constantinou, Varnavas C., और अन्य
  प्रकाशित: (2016)
• Plerixafor+G-CSF–mobilized CD34(+) cells represent an optimal graft source for thalassemia gene therapy
  द्वारा: Karponi, Garyfalia, और अन्य
  प्रकाशित: (2015)
• In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia
  द्वारा: Wang, Hongjie, और अन्य
  प्रकाशित: (2018)